Association ofCCR5Human Haplogroup E with Rapid HIV Type 1 Disease Progression
- 1 February 2005
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 21 (2), 111-115
- https://doi.org/10.1089/aid.2005.21.111
Abstract
The combination of unique single nucleotide polymorphisms in the CCR5 regulatory and in the CCR2 and CCR5 coding regions, defined nine CCR5 human haplogroups (HH): HHA–HHE, HHF*1, HHF*2, HHG*1, and HHG*2. Here we examined the distribution of CCR5 HH and their association with HIV infection and disease progression in 36 HIV-seronegative and 76 HIV-seropositive whites from North America and Spain [28 rapid progressors (RP) and 48 slow progressors (SP)]. Although analyses revealed that HHE frequencies were similar between HIV-seronegative and HIV-seropositive groups (25.0% vs. 32.2%, p > 0.05), HHE frequency in RP was significantly higher than that in SP (48.2% vs. 22.9%, p = 0.002). Survival analysis also showed that HHE heterozygous and homozygous were associated with an accelerated CD4 cell count decline to less than 200 cells/µL (adjusted RH 2.44, p = 0.045; adjusted RH = 3.12, p = 0.037, respectively). These data provide further evidence that CCR5 human haplogroups influence HIV-1 disease progression in HIV-infected persons.Keywords
This publication has 35 references indexed in Scilit:
- Polymorphisms in the CCR5 Coding and Noncoding Regions among HIV Type 1-Exposed, Persistently Seronegative Female Sex-Workers from ThailandAIDS Research and Human Retroviruses, 2003
- CC Chemokine Receptor 5 ?32 and CC Chemokine Receptor 2 64I Polymorphisms Do Not Influence the Virologic and Immunologic Response to Antiretroviral Combination Therapy in Human Immunodeficiency Virus Type 1–Infected PatientsThe Journal of Infectious Diseases, 2002
- Chemokine-receptor genes and AIDS riskNature, 2002
- Associations of CCR5, CCR2, and Stromal Cell–Derived Factor 1 Genotypes with Human Immunodeficiency Virus Disease Progression in Patients Receiving Nucleoside TherapyThe Journal of Infectious Diseases, 2001
- Concordance between the CC Chemokine Receptor 5 Genetic Determinants That Alter Risks of Transmission and Disease Progression in Children Exposed Perinatally to Human Immunodeficiency VirusThe Journal of Infectious Diseases, 2001
- CCR5 Δ32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patientsAIDS, 2000
- Evolution of Human and Non-human Primate CC Chemokine Receptor 5 Gene and mRNAPublished by Elsevier BV ,2000
- No Evidence for an Effect of the CCR5 ?32/+ and CCR2b 64I/+ Mutations on Human Immunodeficiency Virus (HIV)?1 Disease Progression among HIV?1–Infected Injecting Drug UsersThe Journal of Infectious Diseases, 1999
- CCR5 promoter polymorphism and HIV-1 disease progressionThe Lancet, 1998
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996